Announcements Trials

Browse Landscape

Phase

Status

Unknown 1 Recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Glioblastoma 45 Neuroblastoma 16 Glioma 16 Brain Neoplasms 14 Astrocytoma 10 Neoplasms 8 Rhabdomyosarcoma 7 Sarcoma, Ewing 6 Recurrence 5 Oligodendroglioma 5 Medulloblastoma 5 Sarcoma 4 Osteosarcoma 4 Melanoma 4 Small Cell Lung Carcinoma 3 Neuroendocrine Tumors 3 Neuroectodermal Tumors, Primitive 3 Lymphoma 3 Gliosarcoma 3 Diffuse Intrinsic Pontine Glioma 3 Wilms Tumor 2 Rhabdoid Tumor 2 Pyloric Stenosis, Hypertrophic 2 Ovarian Neoplasms 2 Neoplasm Metastasis 2 Ganglioneuroblastoma 2 Fallopian Tube Neoplasms 2 Ependymoma 2 Colorectal Neoplasms 2 Central Nervous System Neoplasms 2

Interventions

Oxaliplatin 13 Bevacizumab 11 Capecitabine 10 Fluorouracil 8 Blood Specimen Collection 8 Leucovorin 7 Cetuximab 6 pembrolizumab 5 Folfox protocol 5 trifluridine tipiracil drug combination 4 dostarlimab 4 Nivolumab 4 Irinotecan 4 HMPL-013 4 Drug Therapy 4 fludarabine 3 XELOX 3 Specimen Handling 3 Laparoscopy 3 IFL protocol 3 Cyclophosphamide 3 Biopsy 3 tislelizumab 2 tipiracil 2 regorafenib 2 pertuzumab 2 envafolimab 2 encorafenib 2 cemiplimab 2 atezolizumab 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Recruiting × Colonic Neoplasms × Temozolomide × Clear all

NCT06490536 2025-08-29

The Sagittarius Trial

IFOM ETS - The AIRC Institute of Molecular Oncology

Phase 3 Recruiting

Gastrointestinal

Colonic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡